Aptorum Group Limited - Class A Ordinary Shares (APM)
1.2900
+0.00 (0.00%)
NASDAQ · Last Trade: Aug 8th, 2:30 AM EDT
Via Benzinga · July 25, 2025
Via Benzinga · July 18, 2025
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · July 18, 2025
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · July 17, 2025
Via Benzinga · July 17, 2025
Via Benzinga · July 16, 2025
Via Benzinga · July 16, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via Chartmill · April 16, 2025
Via Benzinga · April 16, 2025
Via Benzinga · April 15, 2025

Via Benzinga · January 31, 2025

Via Benzinga · December 31, 2024

Via Benzinga · December 31, 2024

Via Benzinga · December 31, 2024

Via Benzinga · December 31, 2024

Via Benzinga · December 31, 2024

Via Benzinga · December 3, 2024

Via Benzinga · December 3, 2024

Via Benzinga · October 28, 2024

Via Benzinga · April 18, 2024

Via Benzinga · April 15, 2024

We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades.
Via InvestorPlace · April 12, 2024

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.
Via Benzinga · March 20, 2024